📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

EROS/CYBC1 mutations: Decreased NADPH oxidase function and chronic granulomatous disease. (2019)

First Author: Thomas DC

Attributed to: A BIOMARKER AND PATHWAY DISCOVERY PROGRAMME IN INFLAMMATORY DISEASE funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.jaci.2018.09.019

PubMed Identifier: 30312704

Publication URI: http://europepmc.org/abstract/MED/30312704

Type: Journal Article/Review

Volume: 143

Parent Publication: The Journal of allergy and clinical immunology

Issue: 2

ISSN: 0091-6749